AFT Pharmaceuticals Ltd. entered an alliance agreement with Angelini Acraf SpA to license AFT's Maxiclear patented combination cold-and-flu product line in an additional 16 countries.

The added countries include Italy, San Marino, Vatican City, Spain, Portugal, Greece, Bulgaria, Croatia, Czech Republic, Slovakia, Austria, Romania, Poland, Hungary, Turkey and Russia.